Business Description
Vivo Bio Tech Ltd
NAICS : 325412
ISIN : INE380K01017
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | 2.63 | |||||
Interest Coverage | 1.66 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.38 | |||||
Beneish M-Score | -2.28 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.5 | |||||
3-Year EBITDA Growth Rate | 15 | |||||
3-Year EPS without NRI Growth Rate | -39.1 | |||||
3-Year Book Growth Rate | 10.7 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.73 | |||||
9-Day RSI | 44.65 | |||||
14-Day RSI | 44.69 | |||||
6-1 Month Momentum % | 36.03 | |||||
12-1 Month Momentum % | 98.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.22 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 761.37 | |||||
Days Sales Outstanding | 90.13 | |||||
Days Payable | 84.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | 7.62 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 91.53 | |||||
Operating Margin % | 28.33 | |||||
Net Margin % | 7.95 | |||||
FCF Margin % | 6.95 | |||||
ROE % | 7.51 | |||||
ROA % | 3.16 | |||||
ROIC % | 8.05 | |||||
ROC (Joel Greenblatt) % | 14.04 | |||||
ROCE % | 14.07 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 16.24 | |||||
PE Ratio without NRI | 16.24 | |||||
Shiller PE Ratio | 17.56 | |||||
PEG Ratio | 2.35 | |||||
PS Ratio | 1.29 | |||||
PB Ratio | 1.2 | |||||
Price-to-Tangible-Book | 1.46 | |||||
Price-to-Free-Cash-Flow | 18.57 | |||||
Price-to-Operating-Cash-Flow | 8.49 | |||||
EV-to-EBIT | 8.8 | |||||
EV-to-EBITDA | 5.3 | |||||
EV-to-Revenue | 2.5 | |||||
EV-to-FCF | 35.99 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.08 | |||||
Earnings Yield (Greenblatt) % | 11.36 | |||||
FCF Yield % | 5.38 | |||||
Forward Rate of Return (Yacktman) % | -4.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vivo Bio Tech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 484.511 | ||
EPS (TTM) (₹) | 2.59 | ||
Beta | 1.48 | ||
Volatility % | 36.84 | ||
14-Day RSI | 44.69 | ||
14-Day ATR (₹) | 2.554848 | ||
20-Day SMA (₹) | 43.1055 | ||
12-1 Month Momentum % | 98.82 | ||
52-Week Range (₹) | 22.31 - 56 | ||
Shares Outstanding (Mil) | 14.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vivo Bio Tech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vivo Bio Tech Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Vivo Bio Tech Ltd Frequently Asked Questions
What is Vivo Bio Tech Ltd(BOM:511509)'s stock price today?
When is next earnings date of Vivo Bio Tech Ltd(BOM:511509)?
Does Vivo Bio Tech Ltd(BOM:511509) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |